Delivery Order SPE2DB22D3010-SPE2DB24FP2EK

Award Date 4/18/24
Potential Completion Date 4/19/24
Potential Value $2.1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,965.57, is a delivery order for SYNVISC-ONE SYRINGE 6ML medical products. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,164.74 firm fixed-price delivery order is for SYNVISC-ONE SYRINGE 6ML, a medical product, with a period of performance through March 14, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,910.00 Firm Fixed Price Delivery Order is for the supply of SYNVISC-ONE SYRINGE 6ML, a medical product, to support federal healthcare programs. The contract has a performance period through July 26, 2024 and was not set aside for any specific business type. Amerisourcebergen holds a significant $999,999,999...
This federal contract award, valued at $198,634.53, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,773.68 firm fixed-price delivery order is for the supply of SYNVISC-ONE SYRINGE 6ML, a medical product, with a period of performance through February 5, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award is a delivery order valued at $28,319.43 awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The contract covers the procurement of SYNVISC-ONE SYRINGE 6ML, a medical product, with a period of performance through July 29, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the Amerisourcebergen Drug Corporation's Corporate Office Division. The $2,486.28 Firm Fixed Price Delivery Order is for the supply of SYNVISC-ONE SYRINGE 6ML, a medical product used for joint therapy. Amerisourcebergen, a major pharmaceutical distribution company, holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This single-award...
This federal contract award, valued at $5,583.50, was issued by the Medical Supply Chain division of the U.S. Department of Defense to AmerisourceBergen Drug Corp's Corporate Office division. The contract is a Delivery Order for the supply of the pharmaceutical product SYNVISC-ONE SYRINGE 6ML, with a completion date of May 22, 2024. AmerisourceBergen Drug Corp holds two Indefinite Delivery Contracts (IDCs) with the U.S. government - one with the Defense Logistics Agency (DLA) Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $5,684.02, is a delivery order for SYNVISC-ONE SYRINGE 6ML. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range...
This federal contract award is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,394.26 firm fixed-price contract is for the supply of SYNVISC-ONE 48MG/6ML 1S, a medical product. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
  • SPE2DB22D3010
    Indefinite Delivery Contract
  • SPE2DB22D3010-SPE2DB24FP2EK
    Delivery Order

This federal contract award, valued at $2,054.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of SYNVISC-ONE SYRINGE 6ML, a pharmaceutical product.

Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. Additionally, Amerisourcebergen holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000.

This specific delivery order does not have a set-aside designation and was awarded on a full and open competition basis, highlighting Amerisourcebergen's competitive position in the federal pharmaceutical supply market. As a major supplier of pharmaceutical products and medical supplies to the U.S. government, Amerisourcebergen leverages its parent company's extensive supply chain network to fulfill government contracts, primarily serving the Department of Defense and Veterans Affairs healthcare systems.

Generated 7/18/24, 9:27 AM